NASDAQ:KPTI

Karyopharm Therapeutics Stock Forecast

etoro logo Buy KPTI
*Your capital is at risk
$8.69
+0.190 (+2.24%)
At Close: Jun 09, 2026
AI Analysis AI Analysis of KPTI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add KPTI to Watchlist?
Some Reasons Why To Add KPTI:
  • +96.2% price growth over the last year
  • High gross margin of 96.0%
  • Strong return on equity of 73.1%
PDF

Karyopharm Therapeutics Inc. stock price ended at $8.69 on Tuesday, after gaining 2.24%
(Updated on Jun 09, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 08, 2026 Gain 2.24%

The Karyopharm Therapeutics Inc. stock price gained 2.24% on the last trading day (Tuesday, 9th Jun 2026), rising from $8.50 to $8.69. During the last trading day the stock fluctuated 6.64% from a day low at $8.44 to a day high of $9.00. The price has risen in 6 of the last 10 days but is still down by -3.12% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 66 thousand more shares were traded than the day before. In total, 324 thousand shares were bought and sold for approximately $2.81 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 24.82% during the next 3 months and, with a 90% probability hold a price between $8.69 and $13.31 at the end of this 3-month period.

KPTI Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Karyopharm Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $9.06 and $8.73. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -11.51%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Karyopharm Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $8.16 and $7.63. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Karyopharm Therapeutics Inc. finds support just below today's level at $8.16. If this is broken, then the next support from accumulated volume will be at $7.63 and $7.21.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.560 between high and low, or 6.64%. For the last week, the stock has had daily average volatility of 7.22%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KPTI) For The Upcoming Trading Day Of Wednesday 10th

For the upcoming trading day on Wednesday, 10th we expect Karyopharm Therapeutics Inc. to open at $8.71, and during the day (based on 14 day Average True Range), to move between $8.32 and $9.06, which gives a possible trading interval of +/-$0.734 (+/-8.81%) up or down from last closing price. If Karyopharm Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 8.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.75 (0.69%) than the support at $8.16 (6.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Karyopharm Therapeutics Inc. stock A Buy?

The Karyopharm Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Karyopharm Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.265 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 10, 2026 - $8.71 ( 0.230%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

KPTI Performance

Trading levels for KPTI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.27 6.67%
R2 9.06 4.21%
R1 8.92 2.69%
Price 8.69
S1 8.50 -2.23%
S2 8.36 -3.75%
S3 8.15 -6.21%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.90 2.42%
R2 8.85 1.84%
R1 8.75 0.690%
Price 8.69
S1 8.16 -6.10%
S2 7.63 -12.20%
S3 7.21 -17.03%

FAQ

What is the symbol for Karyopharm Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Karyopharm Therapeutics Inc. is KPTI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Karyopharm Therapeutics Inc. Stock?
The Karyopharm Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Karyopharm Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Karyopharm Therapeutics Inc. Stock?
Karyopharm Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Karyopharm Therapeutics Inc. Stock.

What's the current price of Karyopharm Therapeutics Inc. Stock?
As of the end of day on the Jun 09, 2026, the price of an Karyopharm Therapeutics Inc. (KPTI) share was $8.69.

What is the 52-week high and low for Karyopharm Therapeutics Inc. Stock?
The 52-week high for Karyopharm Therapeutics Inc. Stock is $10.99 and the 52-week low is $3.71.

What is the market capitalization of Karyopharm Therapeutics Inc. Stock?
As of the Jun 09, 2026, the market capitalization of Karyopharm Therapeutics Inc. is 196.941M.

When is the next earnings date for Karyopharm Therapeutics Inc.?
The upcoming earnings date for Karyopharm Therapeutics Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezo...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
7.38% Jun 05
TPR
$140.47
3.67% Jun 04
N
NVRI
$19.53
8.19% May 20
SAP
$172.39
3.79% May 05
GLBE
$31.61
2.44% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE